Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR5 | P35346 | 12/20 | 0.73 |
| ▸ | SSTR4 | P31391 | 12/20 | 0.73 |
| ▸ | SSTR2 | P30874 | 11/20 | 0.73 |
| ▸ | SSTR3 | P32745 | 8/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21090931 | 0.97 | SSTR5 (0.78) | SSTR5SSTR4SSTR2SSTR3 | |
| SCHEMBL18712336 | 0.97 | SSTR5 (0.78) | SSTR5SSTR4SSTR2SSTR3 | |
| SCHEMBL8262030 | 0.97 | SSTR5 (0.78) | SSTR5SSTR4SSTR2SSTR3 | |
| SCHEMBL18712350 | 0.97 | SSTR5 (0.78) | SSTR5SSTR4SSTR2SSTR3 | |
| SCHEMBL21099493 | 0.96 | SSTR5 (0.77) | SSTR5SSTR4SSTR2SSTR3 | |
| SCHEMBL20822442 | 0.91 | SSTR5 (0.72) | SSTR5SSTR4SSTR2SSTR3 | |
| SCHEMBL21892145 | 0.91 | SSTR5 (0.68) | SSTR5SSTR4SSTR2SSTR3 | |
| SCHEMBL22183423 | 0.90 | SSTR2 (0.76) | SSTR5SSTR4SSTR2SSTR3 | |
| SCHEMBL31476452 | 0.89 | SSTR4 (0.80) | SSTR5SSTR4SSTR2SSTR3 | |
| SCHEMBL21312757 | 0.89 | SSTR5 (0.66) | SSTR5SSTR4SSTR2SSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11517581-B2 | Zika virus protease inhibitors and methods of use thereof | VERSITECH LIMITED (CN) | 2022-12-06 | — | — | US | disclosed |
| US-20200384005-A1 | ZIKA VIRUS PROTEASE INHIBITORS AND METHODS OF USE THEREOF | FUNDACION UNIVERSITARIA SAN ANTONIO (ES) | 2020-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11517581-B2 | Zika virus protease inhibitors and methods of use thereof | CTRL, FURIN, SPINT2 | SSTR5 4804/4885SSTR4 4737/4885SSTR2 4827/4885 |
| US-20200384005-A1 | ZIKA VIRUS PROTEASE INHIBITORS AND METHODS OF USE THEREOF | CTRL, FURIN, SPINT2 | SSTR5 4804/4885SSTR4 4737/4885SSTR2 4827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.